Conference on CNS Clinical Trials
March 15 - 16, 2010(Ended)BSG Conference Centre
London, United Kingdom
London, United Kingdom
CNS is one of the largest and fastest growing therapeutic areas of thepharmaceutical market. The ageing of the baby-boom generation combined
with new and emerging treatments for neurodegenerative disorders, including multiple sclerosis, Alzheimer’s disease and Parkinson’s disease, will lead to further expansion of the neurodegenerative therapies market.
CNS Clinical Trials conference you will examine the strategies offering
the greatest potential for success in CNS drug development, and understand the specifi c
challenges currently faced by developers in this market. In order to enhance productivity
in this fi eld, there has been an increased awareness of the need to align clinical and
preclinical research to facilitate rapid development of new CNS drug therapies. Medical
imaging is increasingly being used as a surrogate endpoint or biomarker of drug effi cacy
in all phases of CNS trials, enabling CNS developers to make more timely decisions.
Venue
Address
236 City Road,
London,
United Kingdom
London,
United Kingdom
Prices *
2477 US Dollar
Organization
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Attending Health conferences is beneficial not only for professionals
- Medical Seminars for All in the Field
- Medical conferences—establishing awareness in medical fields
- Cancer Basic Research
- A Study of clinical profile and treatment outcome of DOTS regime in 250 pulmonary and extra pulmonary patients in Hamidia hospital ,Bhopal in the year 2011
- Correlation existing between the decreasing values of central corneal thickness and worsening of the field defect in primary open angle glaucoma (Health/Opthalmology)
